|
Volumn 183, Issue 1, 2005, Pages 53-62
|
The influence of gastroesophageal reflux disease and its treatment on asthmatic cough
d
NONE
(Hungary)
|
Author keywords
Asthma; Chronic cough; Gastroesophageal reflux disease; Proton pump inhibitor; Respiratory symptoms
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ESOMEPRAZOLE;
PROTON PUMP INHIBITOR;
STEROID;
ANTIULCER AGENT;
OMEPRAZOLE;
ACIDITY;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CONTROLLED STUDY;
COUGHING;
DISEASE EXACERBATION;
DRUG EFFICACY;
FEMALE;
FORCED EXPIRATORY VOLUME;
GASTROESOPHAGEAL REFLUX;
HUMAN;
LUNG FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
OUTCOMES RESEARCH;
PEAK EXPIRATORY FLOW;
PH MEASUREMENT;
PRIORITY JOURNAL;
RESPIRATORY FUNCTION;
STATISTICAL SIGNIFICANCE;
CASE CONTROL STUDY;
METHODOLOGY;
MONITORING;
PATHOPHYSIOLOGY;
PH;
PROSPECTIVE STUDY;
TIME;
ADULT;
ANTI-ULCER AGENTS;
ASTHMA;
CASE-CONTROL STUDIES;
COUGH;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HUMANS;
HYDROGEN-ION CONCENTRATION;
MALE;
MONITORING, PHYSIOLOGIC;
OMEPRAZOLE;
PROSPECTIVE STUDIES;
RESEARCH DESIGN;
TIME FACTORS;
|
EID: 19844378416
PISSN: 03412040
EISSN: None
Source Type: Journal
DOI: 10.1007/s00408-004-2526-z Document Type: Article |
Times cited : (11)
|
References (20)
|